Lipocine Inc. Common Stock (NASDAQ: LPCN) last traded at $1.69, up 4.32% on the session. The quote above updates while this page is open; the figures below are drawn from Lipocine Inc. Common Stock’s own filings and are restated only when a new one is published.
Lipocine Inc. Common Stock trades on NASDAQ under the ticker LPCN. Its market capitalisation is $13.93 million.
Valuation measures for Lipocine Inc. Common Stock, derived from the latest quote and its most recent SEC filing.
| Market cap | $13.93M |
|---|---|
| Enterprise value | $11.02M |
| Price / sales | 8.88 |
| Price / book | 0.64 |
| Beta | 1.43 |
Trailing-twelve-month figures tagged in Lipocine Inc. Common Stock's XBRL filings with the SEC.
| Revenue (TTM) | $1.57M |
|---|---|
| Net income (TTM) | -$11.85M |
| EPS (TTM) | -$1.79 |
| Operating margin | -800.82% |
| Return on equity | -54.45% |
| Cash | $4.98M |
Range and volume for LPCN over the past 52 weeks.
| 52-week high | $12.37 |
|---|---|
| 52-week low | $1.59 |
| Volume | 360.2K |
| Average volume | 1.74M |
| Previous close | $1.62 |
Invest a chosen dollar amount in Lipocine Inc. Common Stock with fractional shares.
Start investingCreate an account
Investing involves risk, including possible loss of principal. Nothing here is investment advice or a recommendation to buy or sell LPCN.
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.